Edge Therapeutics, Inc. Human Resources Contracts & Agreements

Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on July 17, 2023)

Executive Employment Agreement by and between Spencer Brown and PDS Biotechnology Corporation, effective as of June 1, 2022 (Filed With SEC on August 8, 2022)

Executive Employment Agreement by and between Lauren V. Wood, M.D. and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)

Executive Employment Agreement by and between Matthew Hill and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)

Executive Employment Agreement by and between Gregory Conn, Ph.D. and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)

Amended and Restated Executive Employment Agreement by and between Frank K. Bedu-Addo and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)

PDS Biotechnology Corporation Change of Control Severance Plan effective as of March 14, 2022 (Filed With SEC on March 31, 2022)

Executive Employment Agreement by and between PDS Biotechnology Corporation and Matthew Hill, dated as of October 4, 2021 (Filed With SEC on October 6, 2021)

Amendment to Employment Agreement by and between PDS Biotechnology Corporation and Gregory Conn, Ph.D., effective as of June 17, 2021 (Filed With SEC on June 21, 2021)

Form of Employee Stock Option Agreement under the Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)

Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)

Executive Employment Agreement by and between the Company and Seth L. Van Voorhees, Ph.D (Filed With SEC on December 9, 2020)

Consulting Agreement (Michael King) (Filed With SEC on June 24, 2020)

Employment Agreement, effective June 1, 2019, by and between PDS Biotechnology Corporation and Gregory Conn (Filed With SEC on August 1, 2019)

Consulting Services Agreement, dated March 26, 2015, by and between PDS Biotechnology Corporation and Gregory Conn (Filed With SEC on December 21, 2018)

Employment Agreement, dated October 11, 2018, by and between PDS Biotechnology Corporation and Frank K. Bedu-Addo (Filed With SEC on December 21, 2018)

Consulting Services Agreement, dated December 15, 2014, by and between PDS Biotechnology Corporation and Gregory Freitag (Filed With SEC on December 21, 2018)

Consulting Services Agreement, dated December 15, 2014, by and between PDS Biotechnology Corporation and DeLyle Bloomquist (Filed With SEC on December 21, 2018)

Executive Employment Agreement by and between Andrew Saik and Edge entered into as of October 31, 2017 (Filed With SEC on November 1, 2017)

Separation and General Release Agreement, by and between Edge Therapeutics, Inc. and Andrew J. Einhorn, dated March 13, 2017 (Filed With SEC on March 15, 2017)

Employment Agreement by and between Alyssa Wyant and the Company, dated as of February 21, 2017 (Filed With SEC on March 2, 2017)

Executive Employment Agreement by and between Daniel Brennan and Edge Therapeutics, Inc. entered into as of October 17, 2016 (Filed With SEC on October 18, 2016)

EDGE THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN (Filed With SEC on September 21, 2015)

EDGE THERAPEUTICS, INC. 2012 EQUITY INCENTIVE PLAN (Filed With SEC on September 21, 2015)

EDGE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN Adopted by the Board of DirectorsAugust 27, 2014 Approved by the Shareholders November 3, 2014 (Filed With SEC on September 21, 2015)

SECONDAMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 21, 2015)

SECONDAMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)

AMENDEDAND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)

SECONDAMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)

AMENDEDAND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)

EDGE THERAPEUTICS,INC. SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2015)

EDGE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN Adopted by the Board of DirectorsAugust 27, 2014 Approved by the Shareholders November 3, 2014 (Filed With SEC on August 14, 2015)

EDGE THERAPEUTICS, INC. 2012 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2015)

EDGE THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2015)